HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John R Graybill Selected Research

posaconazole

3/2010Efficacy of posaconazole as treatment and prophylaxis against Fusarium solani.
9/2008Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant.
4/2007Salvage treatment of histoplasmosis with posaconazole.
2/2007Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection.
9/2006Coccidioidomycosis.
6/2006Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections.
5/2006Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions.
10/2005Activity of posaconazole in the treatment of central nervous system fungal infections.
6/2005Refractory coccidioidomycosis treated with posaconazole.
10/2004Antifungal therapy of murine Aspergillus terreus infection.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John R Graybill Research Topics

Disease

10Infections
03/2010 - 06/2003
8Aspergillosis
06/2009 - 04/2002
5Body Weight (Weight, Body)
03/2010 - 05/2002
5Invasive Pulmonary Aspergillosis
06/2009 - 04/2006
5Mycoses (Diseases, Fungus)
09/2008 - 06/2003
4Cryptococcal Meningitis
07/2010 - 03/2002
4Coccidioidomycosis
12/2007 - 06/2004
3Meningoencephalitis
06/2012 - 08/2006
3Fusariosis
03/2010 - 05/2006
3Zygomycosis (Phycomycosis)
09/2008 - 05/2002
3Invasive Fungal Infections
09/2008 - 10/2005
3Candidiasis (Moniliasis)
02/2007 - 11/2002
2Acquired Immunodeficiency Syndrome (AIDS)
07/2010 - 08/2006
2Cryptococcosis
02/2010 - 09/2008
2Candidemia
09/2008 - 07/2003
2Cross Infection (Nosocomial Infection)
11/2007 - 07/2007
2Cytomegalovirus Infections (Inclusion Disease)
11/2007 - 07/2007
2Influenza in Birds (Avian Flu)
11/2007 - 07/2007
2Herpes Genitalis (Genital Herpes)
11/2007 - 07/2007
2Histoplasmosis
04/2007 - 04/2002
2scedosporiosis
12/2005 - 04/2003
1adiaspiromycosis
04/2012
1Neoplasms (Cancer)
09/2008
1Critical Illness (Critically Ill)
04/2008
1Central Nervous System Diseases (CNS Diseases)
08/2007
1HIV Infections (HIV Infection)
02/2007
1Febrile Neutropenia
06/2006
1Hematologic Neoplasms (Hematological Malignancy)
05/2006
1Leukemia
05/2006
1Neutropenia
05/2006
1Central Nervous System Fungal Infections
10/2005
1Cerebral Phaeohyphomycosis
05/2005
1Endophthalmitis (Ophthalmia)
01/2005
1Phaeohyphomycosis
06/2004
1Oral Candidiasis (Thrush)
04/2004
1Esophagitis
04/2004

Drug/Important Bio-Agent (IBA)

16posaconazoleFDA Link
03/2010 - 05/2002
11Amphotericin B (Amphotericin)FDA LinkGeneric
07/2010 - 05/2002
6Fluconazole (Zonal)FDA LinkGeneric
02/2010 - 05/2002
6Voriconazole (Vfend)FDA LinkGeneric
06/2009 - 05/2002
6Caspofungin (Cancidas)FDA Link
12/2007 - 07/2003
6Itraconazole (Sporanox)FDA LinkGeneric
07/2007 - 05/2002
5Antifungal AgentsIBA
09/2008 - 10/2005
4liposomal amphotericin BFDA Link
07/2010 - 10/2003
4Pharmaceutical PreparationsIBA
02/2010 - 10/2003
4TriazolesIBA
11/2007 - 05/2002
3AzolesIBA
02/2007 - 04/2004
2deoxycholate drug combination amphotericin BIBA
07/2010 - 12/2007
2LipidsIBA
02/2010 - 06/2004
2AerosolsIBA
07/2008 - 10/2006
2Antiviral Agents (Antivirals)IBA
11/2007 - 07/2007
2SuspensionsIBA
04/2007 - 05/2006
2Micafungin (FK463)FDA Link
01/2005 - 10/2003
1Adrenal Cortex Hormones (Corticosteroids)IBA
04/2012
1Deoxycholic Acid (Sodium Deoxycholate)IBA
07/2010
1Flucytosine (Ancobon)FDA Link
02/2010
1galactomannanIBA
07/2008
1EnzymesIBA
07/2008
1polyglucosanIBA
03/2008
1Biomarkers (Surrogate Marker)IBA
03/2008
1AnidulafunginFDA Link
05/2007
1Virulence Factors (Pathogenicity Factors)IBA
08/2006
1GliotoxinIBA
06/2006
1SolutionsIBA
04/2006
1Retinaldehyde (Retinal)IBA
01/2005
1Biological ProductsIBA
11/2002
1Dihydrotachysterol (AT 10)IBA
05/2002
1DNA (Deoxyribonucleic Acid)IBA
04/2002
1fungiqualIBA
04/2002
1Coloring Agents (Dyes)IBA
04/2002
1Fluorescent Dyes (Fluorescent Probes)IBA
04/2002
118S Ribosomal RNAIBA
03/2002

Therapy/Procedure

18Therapeutics
06/2012 - 06/2003
5Salvage Therapy
03/2010 - 06/2005
1Highly Active Antiretroviral Therapy (HAART)
07/2010
1Aftercare (After-Treatment)
06/2005
1Intravitreal Injections
01/2005